Diagnostic and prognostic implications of non-high-density lipoprotein cholesterol and homocysteine levels for cognitive impairment in thalamic infarction

Table 2 Differences in non-HDL-C and Hcy levels in each group (X ± S)

Group	The number of cases	Non-HDL-C (tendency/L)	Hcy (mol/L)
The control group	50	3.11 ± 0.52	11.66 ± 0.71
Cognitively normal group	45	3.24 ± 0.54	23.22 ± 3.68
Cognitive impairment group	35	3.98 ± 0.871,2	30.34 ± 4.721,2
F/P value	-	6.393/0.000	25.417/0.000

¹P < 0.05 compared with the control group.

²P < 0.05 compared with the group with normal cognitive function.

Non-HDL-C: Non-high-density lipoprotein cholesterol; Hcy: Homocysteine.